At present, there is no reason to think that in the next month Latvia will no longer receive the vaccines of the manufacturer “AstraZeneca”, the National Health Service said. Vaccinations project department.
–
–
Content will continue after the ad
Advertising
–
According to the department, the AstraZeneca manufacturer has initially promised to supply 294,357 doses of vaccine in the second quarter, of which 100,800 doses have been delivered since the beginning of April. Until now, deliveries have been received approximately every one or two weeks, and in the opinion of the department, there is currently no reason to believe that Latvia will not receive full vaccines from this manufacturer in the coming month.
According to the department, there are currently 49,980 doses of AstraZeneca vaccine in stock, all of which are being saved for the second dose. For the next month – until June 14 – it is planned that the doses in stock will be enough.
At the same time, other options for the supply of additional vaccines are being discussed, as well as the possibility of completing the vaccination course with another suitable vaccine, if necessary.
It has already been reported that on Thursday, Health Minister Daniel Pavluts (AP) claimed on the microblogging Twitter that “by modeling various situations,” AstraZeneca’s incoming volumes for several weeks ” Ministry of Health reserve them for white vaccines.
At the same time, the Minister informed that, if necessary, in case of emergency, the vaccination course would be completed with another suitable vaccine according to the recommendations of scientists.
It was also reported that the AstraZeneca vaccine was originally intended to be the main vaccine to be used European Union (ES) population immunization against Covid-19 because it is inexpensive and easy to use. However, this intention failed because the company was unable to meet its delivery obligations on time. In addition, there are concerns that the vaccine may, in very rare cases, cause blood clots, leading to discontinuation or restrictions in several countries.
AstraZeneca has sued AstraZeneca for non-compliance.
Covid-19 vaccines manufactured by Moderna, Pfizer / BioNTech and Johnson & Johnson have also been approved for use in the EU.
–
